Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure–activity relationships, and potential applications
Inflammopharmacology · 2024-06 · 32 (3) · 1659-1704
DOI: 10.1007/s10787-024-01447-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 23.03.2024. Verfasst von Sicheng Zhai und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Engineering, Haojing College of Shaanxi University of Science & Technology, Tongyi Avenue, Xi Xian New District, Xianyang City, 712…. Hauptthemen laut MEDLINE: Sesquiterpenes, Drug Delivery Systems. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 164 Literaturangaben. Gefördert von: 2020 Key Laboratory Project of Xianyang City, Shaanxi Province Key subject of pharmacy engineering of Shaanxi Provincial Traditional Chinese Medicine administration.
Abstract (Originalsprache)
Curcumol (Cur), a guaiane-type sesquiterpenoid hemiketal, is an important and representative bioactive component extracted from the essential oil of the rhizomes of Curcumae rhizoma which is also known as "Ezhu" in traditional Chinese medicine. Recently, Cur has received considerable attention from the research community due to its favorable pharmacological activities, including anti-cancer, hepatoprotective, anti-inflammatory, anti-viral, anti-convulsant, and other activities, and has also exerted therapeutic effect on various cancers, liver diseases, inflammatory diseases, and infectious diseases. Pharmacokinetic studies have shown that Cur is rapidly distributed in almost all organs of rats after intragastric administration with high concentrations in the small intestine and colon. Several studies focusing on structure-activity relationship (SAR) of Cur have shown that some Cur derivatives, chemically modified at C-8 or C-14, exhibited more potent anti-cancer activity and lower toxicity than Cur itself. This review aims to comprehensively summarize the latest advances in the pharmacological and pharmacokinetic properties of Cur in the last decade with a focus on its anti-cancer and hepatoprotective potentials, as well as the research progress in drug delivery system and potential applications of Cur to date, to provide researchers with the latest information, to highlighted the limitations of relevant research at the current stage and the aspects that should be addressed in future research. Our results indicate that Cur and its derivatives could serve as potential novel agents for the treatment of a variety of diseases, particularly cancer and liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Engineering, Haojing College of Shaanxi University of Science & Technology, Tongyi Avenue, Xi Xian New District, Xianyang City, 712046, Shaanxi Province, People's Republic of China.
- Key Laboratory of Basic and New Drug Research in Chinese Medicine, School of Pharmacy, Shaanxi University of Chinese Medicine, Shiji Avenue, Xi Xian New District, Xianyang City, 712046, Shaanxi Province, People's Republ…
- School of Medical Engineering, Haojing College of Shaanxi University of Science & Technology, Tongyi Avenue, Xi Xian New District, Xianyang City, 712046, Shaanxi Province, People's Republic of China. 562671195@qq.com.
Förderung
- 2020 Key Laboratory Project of Xianyang City
- Shaanxi Province Key subject of pharmacy engineering of Shaanxi Provincial Traditional Chinese Medicine administration
Zitieren
APA
Zhai, S., Wang, R., Wang, J., Xu, X., Niu, L., Guo, M., Zhang, Y., Shi, Y., & Tang, X. (2024). Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure–activity relationships, and potential applications. Inflammopharmacology, 32(3), 1659-1704. https://doi.org/10.1007/s10787-024-01447-6
Vancouver
Zhai S, Wang R, Wang J, Xu X, Niu L, Guo M, et al. Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure–activity relationships, and potential applications. Inflammopharmacology. 2024;32(3):1659-1704. doi:10.1007/s10787-024-01447-6
BibTeX
@article{Zhai2024,
author = {Zhai, Sicheng and Wang, Rui and Wang, Jingyuan and Xu, Xiangdong and Niu, Le and Guo, Min and Zhang, Yongling and Shi, Yajun and Tang, Xuexue},
title = {Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure–activity relationships, and potential applications},
journal = {Inflammopharmacology},
year = {2024},
volume = {32},
number = {3},
pages = {1659--1704},
doi = {10.1007/s10787-024-01447-6}
}
EUVIMED